Piperacillin, Tazobactam — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

6 Recruiting

0 Completed trials

12 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 4 Phase IV: 6

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Bacterial infection 2 Abdominal infection 1 Urinary tract infection 1 Sepsis 1 Infection 1

Sponsors using this IMP

Azienda Ospedaliero Universitaria Di Modena 1 Azienda Sanitaria Universitaria Friuli Centrale 1 Centre Hospitalier Universitaire Amiens Picardie 1 Centre Hospitalier Universitaire De Nantes 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Gentofte Hospital 1 Hvidovre Hospital 1 Medical University Of Vienna 1 Pfizer Inc. 1 Pirkanmaan hyvinvointialue 1 Region Hovedstaden 1 Semmelweis University 1

All trials

12 total

Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2) Pending

2024-511420-13-00 Phase II 1 country Gentofte Hospital
Osteoarticular infections on prosthesis: impact of three antibiotic therapies on the digestive microbiota Pending

2024-513298-29-00 Phase II 1 country Centre Hospitalier Universitaire De Nice
Comparing the efficacy and safety of extended (3 h) and intermittent infusion (0.5 h) of beta-lactams (cefepime, ceftriaxone, meropenem, pip… Pending

2024-518115-19-02 Phase IV 1 country Semmelweis University
Evaluation of the Pharmacokinetics of Subcutaneous Administration of Piperacillin/Tazobactam: An Open-Label, Multicentric, Non-Inferiority R… Pending

2024-519663-17-01 Phase II 1 country Azienda Sanitaria Universitaria Friuli Centrale
Continuous antibiotic infusion in children Pending

2025-522809-38-00 Phase III 1 country Pirkanmaan hyvinvointialue
EPISSOC : Randomized controlled trial comparing an Early Pleural Irrigation strategy with Saline to the Standard of Care for the management … Pending

2025-524697-42-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a no… Recruiting

2024-518583-13-00 Phase IV 1 country Azienda Ospedaliero Universitaria Di Modena
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting

2024-514900-16-00 Phase IV 1 country Region Hovedstaden
A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting

2022-501575-12-00 Phase II 4 countries Pfizer Inc.
Antibiotic pharmacokinetics in women with twin pregnancy Recruiting

2024-518564-12-00 Phase IV 1 country Medical University Of Vienna

Showing 1–12 of 12 trials

← All drugs A–Z